Literature DB >> 11471260

Splenectomy in thalassaemia major: experience at Madina Maternity and Children's Hospital, Saudi Arabia.

Z M al Hawsawi1, T I Hummaida, G A Ismail.   

Abstract

Eighteen (32%) of 56 children with thalassaemia major, whose ages ranged from 5 to 12 years (mean 8.8), underwent splenectomy at Madina Maternity and Children's Hospital, Saudi Arabia during the period January 1992 to December 1999. This retrospective study was undertaken with the aim of discovering the outcome. The indications for splenectomy were increased transfusion requirements and massive splenomegaly in 17 children and splenic abscess in one. Polyvalent pneumococcal and Haemophilus influenza vaccines were not available and all the children therefore received intramuscular benzathine penicillin prophylaxis prior to surgery and oral penicillin prophylactically afterwards. Post-splenectomy septicaemia did not occur. The mean transfusion requirement reduced from 2 to 4 weeks and the mean pre-transfusion haemoglobin rose from 6 to 9 g/dl. There were no deaths. We conclude that splenectomy can be performed safely in children over 5 years of age with thalassaemia, and that pre- and post-operative penicillin can be given prophylactically in the absence of the recommended vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471260     DOI: 10.1080/02724930120058232

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

1.  Post Splenectomy Outcome in β-Thalassemia.

Authors:  Rashid H Merchant; Ami R Shah; Javed Ahmad; Alka Karnik; Nooralam Rai
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

2.  Clinical application of serial operations with preserving spleen.

Authors:  H C Jiang; B Sun; H Q Qiao; J Xu; D X Piao; H Yin
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Prevention of overwhelming postsplenectomy infection in thalassemia patients by partial rather than total splenectomy.

Authors:  Anwar K Sheikha; Ziyan T Salih; Kalandar H Kasnazan; Mohammad K Khoshnaw; Talal Al-Maliki; Tarek A Al-Azraqi; Mubarak H Zafer
Journal:  Can J Surg       Date:  2007-10       Impact factor: 2.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.